Conclusion. We demonstrated that increased oxidative stress in the blood circulation of the uraemic patients Background. Iron balance is critical for adequate erythropoiesis and there remains much debate con-on haemodialysis is exacerbated by the elevated baseline serum ferritin levels and intravenous iron infusion. cerning the optimal timing and dosage of iron therapy for haemodialysis patients receiving recombinant The resultant oxidative damage may contribute to the increased incidence of atherosclerosis in the human erythropoietin therapy. Methods. In this study, we examined the influence of patients with end-stage renal disease on long-term haemodialysis. baseline ferritin level and intravenous infusion of 100 mg ferric saccharate on the oxidative status of the Key words: Key words: erythropoiesis; erythropoietin patients on maintenance haemodialysis. The levels of therapy; haemodialysis; intravenous iron therapy; oxidantioxidant enzymes and lipid peroxides were deterative stress; reactive oxygen species; uraemia mined in erythrocytes and plasma of 50 uraemic patients on haemodialysis. These patients were divided into groups 1, 2, and 3, based on their baseline serum ferritin levels of <300, 301-600, and >601 mg/l, Introduction respectively. Results. We found that the mean superoxide dismutase Several lines of evidence have indicated that reactive (SOD) activities in the erythrocytes were similar in the oxygen species (ROS ) may be involved in the uraemic three groups of patients and did not differ from those toxicity of patients with end-stage renal disease of the age-matched controls. On the other hand, all ( ESRD). In addition, these patients are also chronicthe haemodialysis patients showed significantly higher ally exposed to the oxidative stress of ROS as a result plasma SOD activity as compared to controls. After of activation of neutrophils induced by their interaction intravenous iron infusion, group 3 patients showed the with the dialysis membranes [1,2]. Increased concentralargest decrease in plasma SOD activity. The plasma tion of malondialdehyde (MDA), one of the end glutathione peroxidase (GSHPx) activities of the products of the peroxidation of polyunsaturated fatty patients in all three groups and the erythrocyte GSHPx acids, has been reported in plasma and erythrocytes activities of the patients in the groups 2 and 3 were [3] [4] [5] of haemodialysis patients. It has been observed lower than those of the healthy controls. In all three that plasma levels of glutathione (GSH ) [6 ], GSH groups of patients, no difference in GSHPx activity peroxidase (GSHPx) [4], vitamins C [4] and E [5] are was found before and after intravenous iron infusion. decreased in the ESRD patients. Erythrocyte superoxOn the other hand, we found that the average baseline ide dismutase (SOD) activity was reported to be levels of plasma lipid peroxides of all three groups of increased [7] or decreased [8] by different investigators. patients were significantly higher than that of the These studies clearly suggest that oxidative stress is controls. The patients in group 3 with the highest enhanced, as indicated by decreased antioxidant levels serum ferritin levels showed the highest levels of plasma and increased lipid peroxidation, exists in the haemolipid peroxides. More importantly, we found that after dialysis patients. iron infusion, the patients in all three groups, particuThe use of recombinant human erythropoietin larly those in group 3, showed significantly elevated (rHuEpo) to treat the anaemia of patients on maintenlevels of plasma lipid peroxides.
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ance dialysis has been a major advance in the care of these patients. However, this treatment is frequently Correspondence and offprint requests to: Professor Yau-Huei Wei, blunted by the induction of iron depletion [10, 11] .
of haematological parameters and activities of antioxidant accepted mode of treatment for iron deficiency in these enzymes. First, a 1-ml aliquot of blood was removed to patients [12] [13] [14] . Several clinical studies demonstrated determine haemoglobin concentration with a standard kit.
that intensive intravenous iron therapy not only Following centrifugation at 600 g for 10 min, the plasma was improves erythropoiesis, but also results in a tremend-collected and stored in aliquots at −80°C or used immedious decrease (about 41%) in the amount of rHuEpo ately for enzymatic assays. Several aliquots of the same previously required [13, 15] . Later, a consensus report samples were transferred into other tubes to be used for the on diagnosis and correction of iron deficiency recom-assays of other plasma or serum parameters, which were mended intravenous iron therapy for haemodialysis performed by routine laboratory techniques. In addition, an patients [16 ] . Nevertheless, the upper safety limit for aliquot of 1-ml fresh blood was collected in a heparin that iron overload may be indicated by a serum ferritin level greater than 1000 mg/l. A recent study demonstrated a profound impairment of polymorphonuclear Measurement of antioxidant enzyme activities in leukocytes if haemodialysis patients had a serum ferri-erythrocytes and plasma tin level >650 mg/l even if transferrin saturation is below 20% [18] . Clearly, more studies are urgently SOD needed to better define the potential risk of intravenous
The SOD activities in the plasma and erythrocytes were iron therapy. measured by the method described by Oyanagui et al. [19] .
The aim of the present study was to investigate the Plasma or haemolysed erythrocytes, 0.2 mM hydroxylamine, influence of the baseline serum ferritin level and intraand 0.2 mM hypoxanthine were mixed in 1.0 ml of 50 mM venous iron infusion on the levels of the major antiox-Tris-HCl buffer (pH 8.0). The reaction was initiated by idant enzymes and oxidative stress in ESRD patients adding xanthine oxidase (1.25 U/l ) and 10 M EDTA to the receiving maintenance haemodialysis.
reaction mixture and was allowed to proceed at 37°C for 40 min. Diazo dye-forming reagent was added and the rate of change of absorbance at 550 nm was then measured. The
Subjects and methods
activity of SOD is expressed as nitrite U/ml or kU/g Hb.
Patients GSHPx
Twenty male and 30 female patients on regular haemodialysis Plasma or haemolysed erythrocytes, GSH reductase, and treatment for more than 6 months were recruited in this 0.15 M GSH were incubated in 1.0 ml of 50 mM phosphate study after informed consent had been obtained. Their mean buffer (pH 7.0) at 37°C for 10 min. NADPH solution age was 55.8±13.4 years (range 23-80 years). All of the (1.0 mM ) and 5 mM sodium azide were then added and studied patients received erythropoietin therapy. Patients allowed to equilibrate for 3 min at 20°C. The enzymatic underwent haemodialysis three times a week, 4 h per session. reaction was initiated by the addition of 5 mM hydroperoxide Dialysis was carried out with haemophan dialysers (Gambro as the substrate. The conversion of NADPH to NADPH+ AW P-15) and a dialysis bath containing 35 mmol/l bicarbon-was then followed by continuous recording of the decrease ate. No patients had received blood transfusion or oral or in the absorbance at 340 nm for 5 min [20] . GSHPx activity intravenous iron therapy for 3 months preceding the study. is expressed as U/l or U/g Hb. The underlying renal diseases leading to uraemia were chronic glomerulonephritis (28 cases), diabetes mellitus (10 cases),
Glutathione S-transferase
chronic pyelonephritis (4 cases), polycystic kidney disease (3 cases), and unknown causes (5 cases). Baseline serum ferritin The glutathione S-transferase (GST ) activity in the plasma levels were the mean values of three measurements of ferritin or erythrocytes was measured by using 1-chloro-2,4-levels during the 3 months preceding the study. These patients dinitrobenzene (CDNB) as substrate according to the method were then divided into three groups according to the baseline described by Habig et al. [21] . The reaction mixture in 2 ml serum ferritin levels: group 1 serum ferritin between 100 and contained 0.2 M sodium phosphate buffer (pH 6.5), 0.95 mM 300 mg/l; group 2, serum ferritin between 301 and 600 mg/l; CDNB, 0.95 mM GSH, and 0.5 ml plasma or lysed erythroand group 3, serum ferritin above 600 mg/l. In the present cyte suspension. The reaction was initiated by the addition study, after obtaining the baseline samples, 100 mg of ferric of the electrophilic substrate CDNB and the reaction was saccharate was given intravenously as a slow continuous monitored at 25°C spectrophotometrically by the increase of infusion for 1 h to all the patients. Samples for analysis were the absorbance at 340 nm. The background rate in the taken 15 min after the end of the infusion.
absence of test samples was subtracted to correct for the A control group was composed of 20 healthy volunteers, non-enzymatic reaction. The GST activity is expressed as who had no history of renal or haematological diseases (10 U/l or U/g Hb. men and 10 women) with a mean age of 57.7±13.3 years. Blood samples were drawn from the antecubital veins after 12 h of fasting.
Determination of total GSH
An aliquot of 0.05 ml 10% perchloric acid (PCA) was added Collection and preparation of blood samples into 0.1 ml of whole blood to remove proteins by precipitation and centrifugation. Total free GSH (tGSH ) in the whole After a 12-h fast, venous blood samples were taken from each of the patients and control subjects. Blood was collected blood was measured with an enzymatic recycling assay, which employs glutathione reductase to induce a kinetic in EDTA vacutainers and used immediately for the analysis colorimetric reaction of 5,5'-dithiobis-(2-nitrobenzoic acid ) and Scheffe test for multiple comparisons or 2-tailed Kruskal-Wallis test were performed to assess the differences (DTNB) [22] . The rate of change of absorbance at 412 nm was measured within 5 mim. The concentration of tGSH is between groups. Wilcoxon's test was used for analysis of paired data. Pearson's correlation coefficient was used to expressed as mg/ml.
determine the relationship between concentrations of antioxidants and serum ferritin levels. A P value <0.05 was
Determination of total free thiols
considered as significant.
The concentration of plasma thiols was determined by a colorimetric method according to Ellman [23] . An aliquot Results of 0.05 ml 10% PCA was added into 0.1 ml of whole blood to remove proteins by precipitation and centrifugation. The Tables 1 and 2 show the biochemical and haematologsupernatant was added with 0.05 ml of 0.1 M DTNB. After ical data of the patients in different groups that were thorough mixing, the mixture was left standing at room examined in this study. There was no difference in temperature. The final absorbance at 412 nm was recorded BUN, creatinine, albumin, cholesterol, triglycerides, after 30 min reaction of DTNB with all the SH-groupand uric acid among the three groups of patients. All containing compounds. The blood concentration of total free thiols is expressed in the unit of mg/ml.
patients had serum CRP within the normal range (0-0.50 mg/dl ). The average activities of SOD, GSHPx, and GST in Measurement of plasma lipid peroxides the erythrocytes and plasma of the three groups of patients and controls are given in Tables 3, 4 , and 5
Plasma level of lipid peroxides was measured as MDA by an automated HPLC system as described previously [24] . respectively. Erythrocyte SOD activities were similar Five hundred microlitres each of a plasma sample, reagent in all three groups of the haemodialysis patients and blank (distilled water), and 1,1,3,3-tetramethoxypropane did not differ from those observed in the age-matched (TMP) working standard solutions were respectively pipetted controls. Plasma SOD activities of the patients in all into a glass tube. After mixing, 750 ml of 0.44 M phosphoric three groups were found to be higher than that of acid and 250 ml of 0.6% thiobarbituric acid ( TBA) were controls (106.9±10.3 U/ml ). Moreover, patients in added. The mixture was heated for 1 h in boiling water group 3 showed significantly higher plasma SOD activ-(100°C ), and then cooled at 4°C. This was followed by ity than the other two groups, both before and after neutralizing 500 ml of the boiled sample with 500 ml of intravenous iron infusion (P<0.05). After intravenous methanol-1N NaOH mixture (45.554.5, v/v) to precipitate iron infusion, the patients in group 3 again showed proteins before injection into a C18 column. After centrifugation, 10-20 ml of the protein-free supernatant was fraction-the largest and statistically significant decrease ated by HPLC to separate the MDA-TBA adduct from in plasma SOD activity (from 161.4±44.2 to interfering chromogens. The MDA-TBA adduct was quanti-145.1±33.3 U/ml, P<0.05).
fied by a fluorescence detector using the excitation wavelength
The average GSHPx activity in plasma was found of 525 nm and emission wavelength of 550 nm. The concen-to be significantly lower in all the haemodialysis tration of lipid peroxides in the plasma sample is expressed patients as compared with that of controls. Erythrocyte as nmol MDA/ml. A calibration curve was prepared for each GSHPx activities in the patients of groups 2 and 3 run by using 1,1,3,3-tetramethoxypropane as the standard.
were significantly lower than that of the controls. In addition, we found that the erythrocyte GSHPx activitLaboratory evaluation ies of the patients in groups 1 and 2 were significantly higher than those of group 3 patients, both before and Serum levels of total iron, transferrin, ferritin, total protein, after intravenous iron infusion. However, within all albumin, haptoglobin, C-reactive protein (CRP), lactate, three groups of patients, there was no difference in LDH, haematocrit, and transferrin saturation were deterGSHPx activity before and after intravenous iron mined before and 15 min after the infusion. Haematological infusion ( Table 4 ). In addition, we observed a negative parameters including haemoglobin, haematocrit, and erythrocyte index were measured on an automated counter. correlation between GSHPx baseline activity in erythBiochemical assays (blood urea nitrogen (BUN ), creatinine, rocytes (RBC ) and serum ferritin level (r=−0.44, LDH, lactate, and iron) were performed on a multiparametric P<0.001) ( Figure 1 ). Similar negative correlation autoanalyser (Paramax, Baxter, Miami). Haptoglobin and between erythrocytes (RBC ) concentrations of GSHPx CRP levels were determined using a nephelometry method and serum ferritin level was noted after intravenous (Behring, Marburg, Germany). Serum iron and total iron iron infusion. calculated according the following formula: saturation (%)= serum iron/total iron binding capacity.
As shown in Table 5 , the erythrocyte GST activities of the patients in groups 1 and 3 before intravenous iron infusion were higher than those of the controls and Statistical analysis group 2 patients. After the infusion, the erythrocyte GST activities of the patients in the group 1 were
Data are presented as mean±SD. ANOVA followed by
Fisher's protected least significance difference test (PLSD) found to be significantly higher than those of patients dSignificantly different from group 1 after infusion (P<0.05). bSignificantly different from group 3 before infusion (P<0.05).
ANOVA with least significant difference was used to compare the cSignificantly different from group 3 after infusion (P<0.05).
various groups of patients. dSignificantly different from group 3 before infusion (P<0.05). ANOVA with least significant difference was used to compare the various groups of patients. difference in the GST activity after iron infusion. Table 6 shows free thiols and total GSH levels in plasma of all the studied patients before and after iron in groups 2 and 3. We found that group 1 patients with lower baseline level of ferritin exhibited more infusion. The plasma levels of free thiols in all haemodialysis patients were significantly lower than those of drastic increase in the GST activity than did the controls. It is noteworthy that there was no significant the controls. On further analysis, the plasma levels of group 2 ( Table 7) . Furthermore, we found a positive correlation between MDA and serum ferritin level in the patients on haemodialysis (r=0.39, P<0.05) ( Figure 2) .
Haemoglobin, haematocrit, albumin, cholesterol, triglycerides, haptoglobin, and uric acid did not change significantly during iron infusion. LDH was found to rise in all the patients but lactate increased only in the patients of group 3 after iron infusion (2.7±0.7 vs 3.8±1.4 IU/l; P<0.05). As expected, the rise in transferrin saturation 15 min after iron infusion was statistically significant (P<0.001) as shown in Table 2 .
Discussion
The treatment of anaemia in ESRD patients on haemodialysis is frequently hindered by the presence of r = -0.44 P <0.001 Table 7 . Plasma MDA levels in the controls and studied groups of haemodialysis patients ANOVA with least significant difference was used to compare the cSignificantly different from group 3 before infusion (P<0.05).
various groups of patients while Wilcoxon test was used to compare dSignificantly different from group 1 after infusion (P<0.05). paired data. eSignificantly different from group 3 after infusion (P<0.05). fSignificantly different from group 1 (P<0.05). ANOVA with least significant difference was used to compare the various groups of patients. free thiols of group 2 patients were significantly lower than those of patients in the other two groups. On the other hand, we observed significantly lower levels of GSH in the patients of group 2 as compared to controls and group 1 patients. After iron infusion, GSH concentration was significantly increased in patients of all three groups.
Baseline plasma MDA values in all haemodialysis patients were significantly higher than those of the controls. In addition, the patients in group 3 showed significantly higher baseline MDA levels than group 1 patients. Most importantly, we found that after infusion of iron, the patients in all three groups showed significantly elevated plasma levels of MDA. The group 3 patients, who had the highest baseline of serum r = -0.39 P <0.05 ferritin, exhibited significantly higher mean post- infusion MDA values when compared with patients in suboptimal iron stores. Intravenous iron therapy is associated with its metabolism. Two GSH-dependent enzymes that are essential for the disposal of free mandatory to replenish the diminished iron stores. However, little information is available concerning the radicals are GSHPx and GST. GSHPx is a seleniumdependent enzyme [33] and it has been suggested that influence of iron therapy on the oxidative status of uraemic patients.
GSHPx activity is related to the blood selenium level [34] . GSHPx catalyses the reduction of hydrogen perIntracellular ROS bear low specificity in terms of the biological molecules that they attack. Lipid perox-oxide to water at the expense of GSH. On the other hand, GST catalyses the reaction of GSH with elecidation, protein oxidation, and oxidative damage to DNA are the major consequences of the oxidative trophilic reagents [35] such as those generated by microsomal metabolism of drugs and foreign chemicals stress. Fenton reaction, which leads to the formation of hydroxyl radicals or putative organic radicals, has such as acetaminophen and halogenated aromatic hydrocarbons or those generated in the blood of been proposed to mediate most of these oxidative modifications and this reaction requires the participa-uraemic patients. In this study, the GSHPx activities of both erythrocytes and plasma of haemodialysis tion of metal ions such as Fe and Cu [25, 26 ] . Nevertheless, protective mechanisms that inhibit free-patients were lower than those of the controls. These findings are consistent with the results of previous radical reactions as well as non-enzymatic free radical scavengers exist in the animal and human cells to studies [31, 36 ] . It is noteworthy that neither baseline ferritin level nor the intravenous iron infusion directly protect them against free-radical damage. Oxidative stress develops when the levels of these antioxidants affected the enzyme activity of GSHPx in the erythrocytes. are deprived or when production of free radicals exceeds the capacity of the cell to dispose of them.
GSH is usually the most important and abundant physiological thiol compound in tissue cells. It is an In several previous studies [1, 2] , uraemic patients on maintenance haemodialysis were found to be antioxidant that protects the cell against the deleterious effects of ROS and toxic compounds. In uraemic exposed to higher levels of ROS. Owing to such increase in ROS production, lipid peroxidation has patients on regular haemodialysis, blood GSH level was reported to be increased [37] or decreased [6 ] . In been invariably found to be enhanced in the plasma and erythrocytes of uraemic patients [4, 9, 27] . addition, Ceballot-Picot et al. [6 ] found that GSH concentration is closely correlated with the degree of Consistent with these observations, the haemodialysis patients examined in this study displayed a significant renal failure. Its depletion could be due to a decrease of GSH synthesis and/or to an increase of GSH increase of lipid peroxidation and aberration of antioxidant enzymes in the plasma and erythrocytes. An consumption. The results obtained in this study demonstrated that patients with higher baseline level of imbalance between the generation and the removal of ROS and free radicals may be a contributory factor of ferritin have lower concentrations of total GSH and free thiols in plasma. Such negative correlation may haemodialysis-related complications.
The SOD activities in the plasma or erythrocytes be attributed to the increase of oxidative stress in the patients with higher iron stores. Deficiency of GSH were found to be either decreased [8, 28] , increased [7, 9, 29] or unchanged [30] in uraemic patients. In this and free thiols may lead to elevation of free radicals and oxidative stress in the tissue cells. In this study, study, the erythrocyte SOD activities were similar in all three groups of haemodialysis patients and no we observed that after iron infusion, the plasma GSH and free thiols were increased in the patients of all 3 difference was found as compared with those of the controls. Since the erythrocytes lack the ability of de groups. This suggests that acute iron infusion may impose a greater need of GSH to dispose of ROS and novo protein synthesis, no induction of antioxidant enzymes occurs [31] . Correction of anaemia by free radicals, which play an important role in eliciting oxidative stress and oxidative damage in haemodialysis increased erythropoiesis results in an increase of precursor cells of erythrocytes. These young cells are patients.
Moreover, our study showed that the GST activity known to contain elevated levels of SOD activity [32] . Hence during accelerated erythropoiesis, an increase was increased in the erythrocytes of uraemic patients and was further increased in the uraemic patients with in the number of young haematopoietic cells may replenish the erythrocyte SOD activity. Our data the lowest level of serum ferritin. Interestingly, infusion of iron did not significantly change GST activity. This showed that plasma SOD activities were significantly increased in all the haemodialysis patients as compared finding probably indicates that the uraemic milieu with its toxic metabolites may have caused maximal inducto the controls. Meanwhile, those patients in group 3 showed significantly higher plasma SOD activity than tion of this GSH-related defence system [36, 38] . On the other hand, the observed decrease in plasma GST the patients in the other two groups both before and after intravenous iron infusion. After intravenous iron activity in all three groups of uraemic patients may be attributed to the ongoing uraemia-induced imbalance infusion, group 3 patients showed the largest decrease in the plasma SOD activity. This augmented oxidative between oxidants and antioxidants.
Some previous studies demonstrated that uraemic stress probably reflects the deleterious effect of high iron stores.
patients undergoing chronic haemodialysis exhibited augmented lipid peroxidation in the erythrocytes. In The major defence mechanisms against ROSinduced cellular damage include GSH and enzymes plasma, a significant correlation between plasma MDA toxicity in patients with chronic renal failure. Nephron 1994;
and platelet MDA was observed [39] as thrombocytes 66: 76-80 are one of the principal sources of lipid peroxides. All 9. Toborek M, Wasik T, Drozdz M, Lin M, Magner-Wrobel K, three groups of patients showed significant higher increased number of young cells such as reticulocytes [1694] [1695] [1696] [1697] [1698] [1699] in blood circulation of group 2 patients may play an transferrin saturation was over 50% in many patients. [2070] [2071] [2072] [2073] [2074] [2075] [2076] We found a mild increase in LDH after the intravenous 
